By Sarah Rahal and Beth LeBlanc, Detroit News
“A Henry Ford Health System study shows the controversial anti-malaria drug hydroxychloroquine helps lower the death rate of COVID-19 patients, the Detroit-based health system said Thursday.”
By Sarah Rahal and Beth LeBlanc, Detroit News
“A Henry Ford Health System study shows the controversial anti-malaria drug hydroxychloroquine helps lower the death rate of COVID-19 patients, the Detroit-based health system said Thursday.”